2-(Pyrrolidin-1-yl)cyclohexyl (3-(pentyloxy)phenyl)carbamate

Catalog No. :
ACNGLS785
CAS No. :
76629-91-9
Molecular Formula :
C22H34N2O3
Molecular Weight :
374.52

IUPAC Name:2-(pyrrolidin-1-yl)cyclohexyl (3-(pentyloxy)phenyl)carbamate

2-(Pyrrolidin-1-yl)cyclohexyl (3-(pentyloxy)phenyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg97%$57.00Login to see priceInquiryInquiry
5mg97%$136.00Login to see priceInquiryInquiry
10mg97%$202.00Login to see priceInquiryInquiry
25mg97%$330.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyrrolidin-1-yl)cyclohexyl (3-(pentyloxy)phenyl)carbamate
IUPAC Name2-(pyrrolidin-1-yl)cyclohexyl (3-(pentyloxy)phenyl)carbamate
Molecular FormulaC22H34N2O3
Molecular Weight374.52
SMILESO=C(OC1C(N2CCCC2)CCCC1)NC3=CC=CC(OCCCCC)=C3
InChI KeyHVYGHQWGUABUST-UHFFFAOYSA-N
Synonym(2-Pyrrolidin-1-ylcyclohexyl) N-(3-pentoxyphenyl)carbamate;Carbamic acid, [3-(pentyloxy)phenyl]-, 2-(1-pyrrolidinyl)cyclohexyl ester (9CI)
CAS No.76629-91-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNGLS785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGLS785 route product structure diagram
    ACNGLS78576629-91-9
Inquiry

2. ACNGLS785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGLS785 route product structure diagram
    ACNGLS78576629-91-9
Inquiry

Comments (0)